PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32417359-12	2020	RESULTS: We found that simvastatin significantly reduced the protein expression of beta1 integrin by 44% and type I collagen by 60% compared with untreated leiomyoma cells.	Simvastatin	23-34	integrin subunit beta 1	Homo sapiens	83-97	
32417359-16	2020	Furthermore, simvastatin treatment led to reduced levels of mechanical signaling proteins involved in beta1 integrin downstream signaling, such as A-kinase anchor protein 13, Rho-associated protein kinase 1, myosin light-chain kinase, and cyclin D1.	Simvastatin	13-24	integrin subunit beta 1	Homo sapiens	102-116	
21874229-0	2011	Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and beta1 integrin.	Simvastatin	0-11	integrin subunit beta 1	Homo sapiens	116-130	
21874229-9	2011	Expression of the adhesion molecules VCAM-1, ICAM-1 and beta1 integrin chain under the influence of simvastatin 0.1-100 microM for 24-72 h was analyzed using flow cytometry.	Simvastatin	100-111	integrin subunit beta 1	Homo sapiens	56-70	
21395587-14	2011	Simvastatin-treated cells displayed an altered lamellipodia with poorly developed focal adhesion contacts and reduced levels of beta1 integrin activation.	Simvastatin	0-11	integrin subunit beta 1	Homo sapiens	128-142	
17428261-0	2007	Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells.	Simvastatin	0-11	integrin subunit beta 1	Homo sapiens	24-38	
17428261-7	2007	The expression of beta1-integrin, a counter adhesion for the extracellular matrix, phosphorylated FAK, and phosphorylated ERK was decreased by treatment with simvastatin.	Simvastatin	158-169	integrin subunit beta 1	Homo sapiens	18-32